Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Holy Grail treatment for COVID-19 remains out of reach. But options exist

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Back To Forum List View

Holy Grail treatment for COVID-19 remains out of reach. But options exist

10-41

Dec 26, 2020 02:34AM

10-41

Rank: President [?]

Points: 1511 [?]

Votes: 12 Score: 3.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Holy Grail treatment for COVID-19 remains out of reach. But options exist

in response to

Holy Grail treatment for COVID-19 remains out of reach. But options exist

10-41

posted on Dec 26, 2020 02:46AM

Gets even better!

Who knows, maybe RVX is already talking with him?

July 29, 2020

Dr. Srinivas Murthy

Dr. Srinivas Murthy, a clinical associate professor in the department of pediatrics, has been awarded the Health Research Foundation of Innovative Medicines Canada Chair in Pandemic Preparedness Research.

The creation of the research chair was founded by the member companies of Innovative Medicines Canada to support the work of a researcher affiliated with a recognized academic institution.

https://www.med.ubc.ca/news/dr-srinivas-murthy-named-research-chair-in-pandemic-preparedness/

Innovative Medicines Canada represents Canada’s innovative pharmaceutical industry.